Metabolic disturbances in the gray matter of the human brain in autoimmune demyelinating disease of the nervous system and their contribution to the symptomatology of the disease.
Prakhova
L N
LN
Institute of the Human Brain, Russian Academy of Sciences, ul. Akademika Pavlova 9, St. Petersburg, 197376 Russia.
Il'ves
A G
AG
Kataeva
G V
GV
Rudas
M S
MS
Totolyan
N A
NA
Stolyarov
I D
ID
D000293:Adolescent; D000328:Adult; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D018450:Disease Progression; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D007839:Functional Laterality; D005947:Glucose / Q000378:metabolism*; D006624:Hippocampus / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000378:metabolism* / Q000503:physiopathology*; D010487:Periaqueductal Gray / Q000378:metabolism / Q000503:physiopathology; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014055:Tomography, Emission-Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D005947:Glucose